Navigation Links
Joint Statement on Atypical Antipsychotic Use in Children
Date:6/8/2009

s also needed to better understand the risks and benefits of these medications when used over an extended period.

As we know, these medications can also have serious side effects, which is why it is crucial that parents and physicians have as much information as possible in order to make informed decisions and weigh the risk of side effects and adverse reactions against the risk of not treating these very serious diseases. Other treatments for grave childhood illnesses such as cancer can cause hair loss, nausea, compromised immune systems and even death. However, few people question the necessity of these aggressive forms of treatment. Like cancer, aggressive treatment may be needed for some patients with bipolar disorder and schizophrenia, diseases with a higher risk of death than some forms of cancer.

The best way to protect the health of our nation's children and adolescents is to increase access to treatment options and communicate accurate, scientific information that helps parents and physicians cope with and properly treat these devastating illnesses.

Our non-profit national mental health advocacy and medical professional organizations represent consumers, physicians, researchers and the top experts in the field of mental health and neuroscience. For more information about mental illness and treatment, we recommend that you talk to your health care provider or visit our organization websites.

American Academy of Child and Adolescent Psychiatry - www.aacap.org

American Foundation for Suicide Prevention - www.afsp.org

American Psychiatric Association - www.psych.org

Child and Adolescent Bipolar Foundation - '/>"/>

SOURCE Mental Health America
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. ASH and EHA Jointly Announce Translational Research Training in Hematology Program
2. ASH and EHA jointly announce translational research training in hematology program
3. Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations
4. Joint Replacement Consumer Awareness Campaign Endorsed by Prominent Orthopaedic Scientist
5. MIT is pleased to announce that it has signed the Joint Venture agreement with its Chinese partners and has received an initial order of 120 units for Animal vaccination
6. Winner Medical Establishes Joint Venture With West China Hospital in Chengdu, China
7. Joint Statement from AHCA, NCAL, and the Alliance on the Obama Administrations FY 2010 Budget
8. Bausch & Lomb and 20/10 Perfect Vision Finalize Refractive Surgery Joint Venture
9. Dr. Michael B. Cates Takes Leadership Role on AVMAs One Health Joint Steering Committee
10. Joint Commission Awards TeamHealth Teleradiology Second Consecutive Gold Seal of Approval(TM)
11. Specialists On Call Renews Joint Commission Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 2Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 3Health News:VHI Releases Annual Industry Report - Highlights Hospital, Nursing Facility Efficiency 2Health News:UPMC Health Plan Offers Brain Fitness Software to Improve Health 2Health News:UPMC Health Plan Offers Brain Fitness Software to Improve Health 3Health News:MassMutual Recognized as One of America's Healthiest Companies 2Health News:MassMutual Recognized as One of America's Healthiest Companies 3Health News:New research identifies modifiable risk factors for heart disease 2Health News:New research identifies modifiable risk factors for heart disease 3Health News:New research identifies modifiable risk factors for heart disease 4Health News:New research identifies modifiable risk factors for heart disease 5Health News:New research identifies modifiable risk factors for heart disease 6
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Debate on admin of magnesium sulfate to pregnant women to prevent cerebral palsy in pre term infants 9043 1Debate on admin of magnesium sulfate to pregnant women to prevent cerebral palsy in pre term infants 9043 2Female human embryos adjust the balance of X chromosomes before implantation 9041 1Female human embryos adjust the balance of X chromosomes before implantation 9041 2Female human embryos adjust the balance of X chromosomes before implantation 9041 3Female human embryos adjust the balance of X chromosomes before implantation 9041 4The National Council on Aging and CVS pharmacy Educate Pennsylvania Seniors on Medication Management and How to Save Money on Prescription Drugs 50279 1The National Council on Aging and CVS pharmacy Educate Pennsylvania Seniors on Medication Management and How to Save Money on Prescription Drugs 50279 2The National Council on Aging and CVS pharmacy Educate Pennsylvania Seniors on Medication Management and How to Save Money on Prescription Drugs 50279 3The National Council on Aging and CVS pharmacy Educate Pennsylvania Seniors on Medication Management and How to Save Money on Prescription Drugs 50279 4